Literature DB >> 15861210

Mitochondrial DNA mutations in human disease.

Robert W Taylor1, Doug M Turnbull.   

Abstract

The human mitochondrial genome is extremely small compared with the nuclear genome, and mitochondrial genetics presents unique clinical and experimental challenges. Despite the diminutive size of the mitochondrial genome, mitochondrial DNA (mtDNA) mutations are an important cause of inherited disease. Recent years have witnessed considerable progress in understanding basic mitochondrial genetics and the relationship between inherited mutations and disease phenotypes, and in identifying acquired mtDNA mutations in both ageing and cancer. However, many challenges remain, including the prevention and treatment of these diseases. This review explores the advances that have been made and the areas in which future progress is likely.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15861210      PMCID: PMC1762815          DOI: 10.1038/nrg1606

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  170 in total

Review 1.  Nuclear genetic defects of oxidative phosphorylation.

Authors:  E A Shoubridge
Journal:  Hum Mol Genet       Date:  2001-10-01       Impact factor: 6.150

2.  Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA.

Authors:  K Nakada; K Inoue; T Ono; K Isobe; A Ogura; Y I Goto; I Nonaka; J I Hayashi
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

3.  Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease.

Authors:  S Srivastava; C T Moraes
Journal:  Hum Mol Genet       Date:  2001-12-15       Impact factor: 6.150

4.  High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples.

Authors:  E Kirches; G Krause; M Warich-Kirches; S Weis; T Schneider; B Meyer-Puttlitz; C Mawrin; K Dietzmann
Journal:  Int J Cancer       Date:  2001-08-15       Impact factor: 7.396

5.  Mitochondrial mutations in early stage prostate cancer and bodily fluids.

Authors:  C Jerónimo; S Nomoto; O L Caballero; H Usadel; R Henrique; G Varzim; J Oliveira; C Lopes; M S Fliss; D Sidransky
Journal:  Oncogene       Date:  2001-08-23       Impact factor: 9.867

Review 6.  Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options.

Authors:  D R Thorburn; H H Dahl
Journal:  Am J Med Genet       Date:  2001

7.  Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects.

Authors:  T Taivassalo; E A Shoubridge; J Chen; N G Kennaway; S DiMauro; D L Arnold; R G Haller
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

8.  Mitochondrial gene mutations in the tRNA(Leu(UUR)) region and diabetes: prevalence and clinical phenotypes in Japan.

Authors:  K Ohkubo; A Yamano; M Nagashima; Y Mori; K Anzai; Y Akehi; R Nomiyama; T Asano; A Urae; J Ono
Journal:  Clin Chem       Date:  2001-09       Impact factor: 8.327

Review 9.  Ooplasmic donation in humans: the potential for epigenic modifications.

Authors:  Susan M Hawes; Carmen Sapienza; Keith E Latham
Journal:  Hum Reprod       Date:  2002-04       Impact factor: 6.918

10.  Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice.

Authors:  L Sörensen; M Ekstrand; J P Silva; E Lindqvist; B Xu; P Rustin; L Olson; N G Larsson
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

View more
  579 in total

1.  Some physicochemical properties of hemoglobin-manitoba (alpha2 102Ser replaced by Arg (G9) beta2).

Authors:  R N Wrightstone; L L Smith; J B Wilson; F Vella; T H Huisman
Journal:  Biochim Biophys Acta       Date:  1975-12-15

2.  Disconnecting XRCC1 and DNA ligase III.

Authors:  Sachin Katyal; Peter J McKinnon
Journal:  Cell Cycle       Date:  2011-07-15       Impact factor: 4.534

3.  Kinetics of tRNA folding monitored by aminoacylation.

Authors:  Hari Bhaskaran; Annia Rodriguez-Hernandez; John J Perona
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

Review 4.  Epigenetics, epidemiology and mitochondrial DNA diseases.

Authors:  Patrick F Chinnery; Hannah R Elliott; Gavin Hudson; David C Samuels; Caroline L Relton
Journal:  Int J Epidemiol       Date:  2012-01-28       Impact factor: 7.196

5.  A "Copernican" reassessment of the human mitochondrial DNA tree from its root.

Authors:  Doron M Behar; Mannis van Oven; Saharon Rosset; Mait Metspalu; Eva-Liis Loogväli; Nuno M Silva; Toomas Kivisild; Antonio Torroni; Richard Villems
Journal:  Am J Hum Genet       Date:  2012-04-06       Impact factor: 11.025

6.  The mitochondrial transcription factor A functions in mitochondrial base excision repair.

Authors:  Chandrika Canugovi; Scott Maynard; Anne-Cécile V Bayne; Peter Sykora; Jingyan Tian; Nadja C de Souza-Pinto; Deborah L Croteau; Vilhelm A Bohr
Journal:  DNA Repair (Amst)       Date:  2010-08-23

7.  Defects in mitochondrial axonal transport and membrane potential without increased reactive oxygen species production in a Drosophila model of Friedreich ataxia.

Authors:  Yujiro Shidara; Peter J Hollenbeck
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

Review 8.  Mitochondrial pathways in human health and aging.

Authors:  Rebecca Bornstein; Brenda Gonzalez; Simon C Johnson
Journal:  Mitochondrion       Date:  2020-07-30       Impact factor: 4.160

Review 9.  Exploiting oxidative microenvironments in the body as triggers for drug delivery systems.

Authors:  Shivanjali Joshi-Barr; Caroline de Gracia Lux; Enas Mahmoud; Adah Almutairi
Journal:  Antioxid Redox Signal       Date:  2014-04-15       Impact factor: 8.401

Review 10.  Review: Mitochondria and disease progression in multiple sclerosis.

Authors:  D Mahad; H Lassmann; D Turnbull
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.